Table 1 Results of the drug susceptibility test of MTB isolates enrolled in this study
No. | INH 0.2(μg/mL) | INH 1.0 (μg/mL) | RIF 1.0 (μg/mL) | EM 5.0 (μg/mL) | EM 10.0 (μg/mL) | S 2.0 (μg/mL) | S 10.0 (μg/mL) |
|---|---|---|---|---|---|---|---|
1 | R | S | S | S | S | S | S |
2 | R | S | S | S | S | S | S |
3 | R | S | S | R | S | S | S |
4 | R | S | R | R | S | R | R |
5 | R | S | R | R | S | S | S |
6 | R | S | S | R | S | S | S |
7 | R | S | S | S | S | S | S |
8 | R | S | S | S | S | S | S |
9 | R | S | S | S | S | S | S |
10 | R | S | S | S | S | R | R |
11 | R | S | R | S | S | S | S |
12 | R | S | S | S | S | S | S |
13 | R | S | R | S | S | S | S |
14 | R | S | S | S | S | S | S |
15 | R | S | R | S | S | R | R |
16 | R | S | R | R | S | S | S |
17 | R | S | R | S | S | S | S |
18 | R | S | S | S | S | S | S |
19 | R | S | S | S | S | S | S |
20 | R | S | S | S | S | S | S |
21 | R | R | S | S | S | S | S |
22 | R | R | R | R | S | R | S |
23 | R | R | S | S | S | R | S |
24 | R | R | S | S | S | R | R |
25 | R | R | S | S | S | R | R |
26 | R | R | R | R | S | R | R |
27 | R | R | S | S | S | R | R |
28 | R | R | S | S | S | S | S |
29 | R | R | R | S | S | S | S |
30 | R | R | S | R | S | S | S |
31 | R | R | S | S | S | S | S |
32 | R | R | S | S | S | S | S |
33 | R | R | R | R | S | R | R |
34 | R | R | S | S | S | R | S |
35 | R | R | S | S | S | R | S |
36 | R | R | S | S | S | R | S |
37 | R | R | S | S | S | S | S |
38 | R | R | S | R | S | S | S |
39 | R | R | S | S | S | R | S |
40 | R | R | S | S | S | R | R |
41 | R | R | S | R | S | S | S |
42 | R | R | R | R | S | R | S |